Dallas, Texas (PRWEB) November 20, 2014
The clinical trial report, "Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014" provides data on the Rheumatoid Arthritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Rheumatoid Arthritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Rheumatoid Arthritis. Complete Report is Available @ http://www.reportsnreports.com/reports/317200-rheumatoid-arthritis-global-clinical-trials-review-h2-2014.html .
Top Companies discussed in this Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014 report include F. Hoffmann-La Roche Ltd., Pfizer Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, Johnson & Johnson, C. H. Boehringer Sohn AG & Co. KG, Amgen Inc., Merck & Co., Inc., UCB S.A.
Top Institutes / Government discussed in this Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014 report include National Institute of Arthritis and Musculoskeletal and Skin Diseases, Academic Medical Center, Osaka City University, University of Occupational and Environmental Health, Japan, University of Leeds, Leiden University Medical Center, University of California, Los Angeles, Department of Health, UK, Saitama Medical University, Tabriz University of Medical Sciences. Order a Purchase copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=317200 .
Latest Clinical Trials News on Rheumatoid Arthritis: ABLYNX'S ANTI-IL-6R Nanobody Partnered With Abbvie Demonstrates A Bioavailability Of More Than 80% After Subcutaneous Injection. Compugen Announces Presentations of Results for CGEN-15001 Supporting Immune Tolerance Induction. EPIRUS Announces Positive 58 Week Follow up Data for BOW015 for Treatment of Rheumatoid Arthritis. Galapagos reports high participation rate in long term extension study with GLPG0634 in RA patients. Biotest completes recruitment in Phase IIb study (TREAT 2b) of Tregalizumab (BT-061) in patients with rheumatoid arthritis. Protalex Announces Acceptance of Abstract Highlighting Findings from U.S. Phase 1(b) Trial of PRTX-100 in Active Rheumatoid Arthritis Patients at the 2014 American College of Rheumatology Annual Meeting. Initiation of Phase 3 Trial of CHS-0214 (Investigational Etanercept Biosimilar) in Japan (RApsody). Coherus Announces CHS-1420 (Investigational Adalimumab Biosimilar) Meets Primary Endpoint in Pivotal Pharmacokinetic Clinical Study. New Data Shows High Efficacy for Can-Fite's CF101 in Rheumatoid Arthritis and Psoriasis Patients. Novimmune Reports Successful Completion of Phase I trial for NI-0101. Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=317200 . (This is a premium report priced at US$2500 for a single user License.)
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Explore more reports on Pharmaceuticals industry at http://www.reportsnreports.com/market-research/pharmaceuticals/ .
ReportsnReports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.